Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
2 clusters · 2 sources · 22 days · First seen · Last updated
Medical diagnostic and testing market trends
Overview
The medical testing sector is seeing growth across different specialized segments. The global Point-of-Care Testing (POCT) market is projected to increase from approximately US$22.69 billion in 2025 to US$36.83 billion by 2032, driven by a shift toward integrated clinical decision-making platforms and rising demand for rapid testing in chronic disease management and infectious diseases.
Simultaneously, the bioanalytical testing services market is expected to grow from an estimated $5.66 billion in 2025 to $16.47 billion by 2036. This growth is fueled by the increasing complexity of modern therapeutics, such as precision medicines and antibody-drug conjugates, which require specialized analytical methods for drug discovery and clinical trials.
Entities
ICH · Abbott · Thermo Fisher Scientific · Siemens Healthineers · Danaher
Timeline
-
[BUSINESS] 2 sourcesBioanalytical testing services market projected to reach $16.47 billion by 2036
The bioanalytical testing services market is forecasted to grow at a 10.2% CAGR, reaching $16.47 billion by 2036, driven by complex drug development and outsourcing trends.
-
[BUSINESS] 2 sourcesGlobal POCT market projected to reach US$36.83 billion by 2032
The global POCT market is expected to reach US$36.83 billion by 2032, growing at a 7.27% CAGR as testing shifts toward integrated clinical decision platforms.
Sources
dreamnews.jp · tmtpost.com